Garvan Institute of Medical Research

The laboratory has pioneered a mounting body of evidence that somatic mutationsin rogue clones of B and/or T cells are a key step in the pathogenesis ofautoimmune diseases allowing these cells to evade normal checkpoints thatmaintainself-tolerance. Until recently technologies forident

The laboratory has pioneered a mounting body of evidence that somatic mutationsin rogue clones of B and/or T cells are a key step in the pathogenesis ofautoimmune diseases allowing these cells to evade normal checkpoints thatmaintainself-tolerance. Until recently technologies forident

The laboratory has pioneered a mounting body of evidence that somatic mutationsin rogue clones of B and/or T cells are a key step in the pathogenesis ofautoimmune diseases allowing these cells to evade normal checkpoints thatmaintainself-tolerance. Until recently technologies forident

The laboratory has pioneered a mounting body of evidence that somatic mutationsin rogue clones of B and/or T cells are a key step in the pathogenesis ofautoimmune diseases allowing these cells to evade normal checkpoints thatmaintainself-tolerance. Until recently technologies forident

The Garvan Research Foundation (GRF) was founded in 1981 and is the fundraising and marketing arm of the Institute raising awareness and vital funds from individuals trusts and foundations and corporate and community groups.THE OPPORTUNITYThe Mid-Value Donor Co-ordinator will report t

The Garvan Research Foundation (GRF) was founded in 1981 and is the fundraising and marketing arm of the Institute raising awareness and vital funds from individuals trusts and foundations and corporate and community groups.THE OPPORTUNITYThe Mid-Value Donor Co-ordinator will report t

The Garvan Research Foundation (GRF) was founded in 1981 and is the fundraising and marketing arm of the Institute raising awareness and vital funds from individuals trusts and foundations and corporate and community groups.THE OPPORTUNITYThe Mid-Value Donor Co-ordinator will report t

The Garvan Research Foundation (GRF) was founded in 1981 and is the fundraising and marketing arm of the Institute raising awareness and vital funds from individuals trusts and foundations and corporate and community groups.THE OPPORTUNITYThe Mid-Value Donor Co-ordinator will report t

The Oncofetal Ecosystem lab is involved in research at the intersection of cancer genomicsand immunology and is committed to the development of next generation of medical therapies.The research in the laboratory involvescutting edgesingle-cell and spatial transcriptomicstechnologies b

The Oncofetal Ecosystem lab is involved in research at the intersection of cancer genomicsand immunology and is committed to the development of next generation of medical therapies.The research in the laboratory involvescutting edgesingle-cell and spatial transcriptomicstechnologies b

The Garvan Research Foundation was founded in 1981 and is the fundraising and marketingarm of the Institute raising awareness and vital funds from individuals trusts and foundationsand corporate and community groups.The Foundations income has grown from a fundraising base of $110000 i

The Garvan Research Foundation was founded in 1981 and is the fundraising and marketingarm of the Institute raising awareness and vital funds from individuals trusts and foundationsand corporate and community groups.The Foundations income has grown from a fundraising base of $110000 i

The Data Science Platform (DSP) brings together experts in Research Computing SoftwareEngineering and Computational Biology to support data-intensive biomedical research. Aspart of Garvans AI strategy DSP isestablishinga dedicated AI team to act as the institutesoperational engine for

The Data Science Platform (DSP) brings together experts in Research Computing SoftwareEngineering and Computational Biology to support data-intensive biomedical research. Aspart of Garvans AI strategy DSP isestablishinga dedicated AI team to act as the institutesoperational engine for